440 filings
Page 3 of 22
8-K
zyrc98hb ang
31 Jul 23
Other Events
9:47pm
D
wj41ifmdjwx
28 Jul 23
$10.00 mm in equity / options / securities to be acquired, sold $10.00 mm, 10 investors
2:07pm
8-K
3da9yf03z7q6 wdf3
21 Jul 23
Entry into a Material Definitive Agreement
8:15am
8-K
7dp1h6tg
15 Jun 23
Other Events
4:06pm
8-K
6m2ubb o4o9nw
10 May 23
AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
8-K
lh2k5sud407
28 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
UPLOAD
6c7qn1axy7qdq2
11 Apr 23
Letter from SEC
12:00am
CORRESP
to5umn5
11 Apr 23
Correspondence with SEC
12:00am
8-K
sicjct1q
7 Apr 23
AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals
3:37pm
8-K
i2qf3oaaq5qy jk5pa
30 Mar 23
AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
UPLOAD
kqxujoh
30 Mar 23
Letter from SEC
12:00am
8-K
ojyzg
16 Mar 23
Entry into a Material Definitive Agreement
4:15pm
8-K
2jmv ye9pngg6k2
29 Dec 22
Other Events
6:03am
424B5
8lpd1widxy8 plaxu
28 Dec 22
Prospectus supplement for primary offering
5:26pm
8-K
wo0g90t1
5 Dec 22
Termination of a Material Definitive Agreement
5:25pm
EFFECT
0qvolxvf3ah rha
23 Nov 22
Notice of effectiveness
12:15am
424B7
amna6vr
22 Nov 22
Prospectus with selling stockholder info
4:29pm